Lisdexamfetamine
Back to searchMolecule Structure
Scientific Name
Lisdexamfetamine
Description of the Drug
Lisdexamfetamine is a central nervous system (CNS) stimulant used to treat attention deficit hyperactivity disorder (ADHD) and moderate to severe eating disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01255
http://www.drugbank.ca/drugs/DB01255
Brand Name(s)
Not Available
Company Owner(s)
Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL238 |
Norepinephrine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL222 |
Synaptic vesicular amine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL1893 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL158949 | ||
Human Metabolome Database | HMDB0015385 | ||
DrugBank | DB01255 | ||
PubChem: Thomson Pharma | 16843305 | ||
PubChem | 11597698 | ||
Nikkaji | J3.292.539A | ||
EPA CompTox Dashboard | DTXSID00209652 | ||
DrugCentral | 4135 | ||
Guide to Pharmacology | 7213 | ||
rxnorm | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE |
ChEBI | 135925 | ||
ZINC | ZINC000011680943 |